Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mahammedi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
La Revue De Medecine Interne|September 16, 2000
[A hazardous electrocardiogram]F Philippot, M André, H Mahammedi, et al.
La Revue De Medecine Interne|April 28, 2004
[Dyskeratosis congenita and diffuse lung fibrosis]C Hafsaoui, H Mahammedi, P Manzoni, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 5, 2013
[Medical treatment of renal cell carcinoma]L Guy, J-O Bay, C Bastide, et al.
La Revue De Medecine Interne|October 6, 2001
[Diverticular sigmoiditis and false increase of CKMB isoenzymes: diagnostic trap to keep in mind]T Mathevon, C Perrier, H Mahammedi, et al.
La Revue De Medecine Interne|July 11, 2002
[Long live springtime! My mother...it is not a trap...]J L Dupond, H Gil, J C Navellou, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 5, 2013
[Medical treatment of bladder carcinoma]L Guy, H Mahammedi, C Bastide, et al.
Annals of the Rheumatic Diseases|June 2, 2000
A "missed" cryoglobulin: the importance of in vitro calcium concentrationM André, H Mahammedi, O Aumaitre, et al.
Bone|March 22, 2005
Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one caseJ L Dupond, H Mahammedi, D Prié, et al.
Oncology|November 7, 2012
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errorsE Thivat, I Van Praagh, A Belliere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancerK Fizazi, K N Chi, N D Shore, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
La Revue De Medecine Interne|September 16, 2000
[A hazardous electrocardiogram]F Philippot, M André, H Mahammedi, et al.
La Revue De Medecine Interne|April 28, 2004
[Dyskeratosis congenita and diffuse lung fibrosis]C Hafsaoui, H Mahammedi, P Manzoni, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 5, 2013
[Medical treatment of renal cell carcinoma]L Guy, J-O Bay, C Bastide, et al.
La Revue De Medecine Interne|October 6, 2001
[Diverticular sigmoiditis and false increase of CKMB isoenzymes: diagnostic trap to keep in mind]T Mathevon, C Perrier, H Mahammedi, et al.
La Revue De Medecine Interne|July 11, 2002
[Long live springtime! My mother...it is not a trap...]J L Dupond, H Gil, J C Navellou, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 5, 2013
[Medical treatment of bladder carcinoma]L Guy, H Mahammedi, C Bastide, et al.
Annals of the Rheumatic Diseases|June 2, 2000
A "missed" cryoglobulin: the importance of in vitro calcium concentrationM André, H Mahammedi, O Aumaitre, et al.
Bone|March 22, 2005
Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one caseJ L Dupond, H Mahammedi, D Prié, et al.
Oncology|November 7, 2012
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errorsE Thivat, I Van Praagh, A Belliere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancerK Fizazi, K N Chi, N D Shore, et al.
Pageof 1